Abstract
Approximately 90 different mutations associated with ornithine transcarbamylase (OTC) deficiency are currently known. Thus, the majority represent private mutations. However, some of the mutations seemed to be recurrent. Our laboratories identified apparent deleterious mutations in 78 consecutive families with OTC deficiency by screening all exons and exon/intron borders using single-strand conformational polymorphism (75 families) or sequencing of the entire coding sequence (3 families). Large deletions of one or more exons were found in 8% of families and approximately 10% had small deletions or insertions of 1–5 bases. Splice site mutations were found in 18% of families. Contrary to previous reports, recurrent point mutations seemed to be equally distributed among most CpG dinucleotides rather than show prevalent mutations. No single point mutation had a relative frequency of more than 6.4%. Of the 64 families with nucleotide substitutions, 24 (38%) were G to A with the next most common being C to T (16%) and A to T (11%).
Similar content being viewed by others
References
Brusilow SW, Horwich AL (1995) Urea cycle enzymes. In: Scriver R, Beaudet AL, Sly WS, Valle D (eds) The molecular and metabolic bases of inherited disease. McGraw-Hill, New York, pp 1187–1232
Copper DN, Krawczak M, Antonarakis SE (1995) The nature and mechanisms of human mutation. In: Scriver R, Beaudet AL, Sly WS, Valle D (eds) The molecular and metabolic bases of inherited disease. McGraw-Hill, New York, pp 259–291
Driscoll DJ, Migeon BR (1990) Sex difference in methylation of single copy genes in human meiotic germ cells: implications for X chromosome inactivation, parental imprinting, and origin of CpG mutations. Somat Cell Mol Genet 16:267–282
García-Pérez MA, Sanjurio P, Rubio V (1995) Demonstration of thespf-ash mutation in Spanish patients with ornithine transcarbamylase deficiency of moderate severity. Hum Genet 95: 183–186
Hata A, Tsuzuki T, Shimada K, Takiguchi M, Mori M, Matsuda I (1988) Structure of the human ornithine transcarbamylase gene. J Biochem 103:302–308
Hata A, Matsuura T, Setoyama C, Shimada K, Yokoi T, Akaboshi I, Matsuda I (1991) A novel missense mutation in exon 8 of the ornithine transcarbamylase gene in two unrelated male patients with mild ornithine transcarbamylase deficiency. Hum Genet 87:28–32
Horwich AL, Fenton WA, Williams KR, Kalousek F, Kraus JP, Doolittle RF, Konigsberg W, Rosenberg LE (1984) Structure and expression of a complementary DNA for the nuclear coded precursor of human mitochondrial ornithine transcarbamylase. Science 224:1068–1074
Maddalena A, Edward SJ, O'Brien WE, Nussbaum RL (1988) Characterization of point mutations in the same arginine codon in three unrelated patients with ornithine transcarbamylase deficiency. J Clin Invest 82:1353–1358
Tuchman M (1993) Mutations and polymorphisms in the human ornithine transcarbamylase gene. Hum Mutat 2:174–178
Tuchman M, Plante RJ (1995) Mutations and polymorphisms in the human ornithine transcarbamylase gene: mutation update addendum. Hum Mutat 5:293–295
Tuchman M, Holzknecht RA, Gueron AB, Berry SA, Tsai MY (1992) Six new mutations in the ornithine transcarbamylase gene detected by single-strand conformation polymorphism. Pediatr Res 32:600–604
Tuchman M, Matsuda I, Munnich A, Malcolm S, Strautnieks S, Briede T (1995) Proportions of spontaneous mutations in males and females with ornithine transcarbamylase deficiency. Am J Med Genet 55:67–70
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tuchman, M., Plante, R.J., García-Pérez, M.A. et al. Relative frequency of mutations causing ornithine transcarbamylase deficiency in 78 families. Hum Genet 97, 274–276 (1996). https://doi.org/10.1007/BF02185751
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02185751